openPR Logo
Press release

Urothelial Carcinoma Treatment Market : Evolving Market Trends & Dynamics 2024

07-18-2017 08:17 PM CET | Health & Medicine

Press release from: Transparency Market Research

Urothelial Carcinoma Treatment Market : Evolving Market Trends

Urothelial carcinoma is a malignant neoplasm resulting from transitional epithelium, occurring mainly in the urinary bladder, renal pelves or ureters; frequently papillary. These carcinomas are classified according to the degree of anaplasia. Urothelial cell carcinoma (UCC) is a type of cancer that normally occurs in the urinary system: urinary bladder, kidney and accessory organs. It is the most common type of bladder, ureter, urethra, and urachus cancer. Urothelial cell carcinoma is also known as transitional cell carcinoma. Bladder transitional cell carcinoma (TCC) is the most common tumor of the entire urinary system and TCC is the most common primary neoplasm of the urinary bladder. Cancer of the ureter may not have symptoms in the early stages of the disease. However, symptoms may appear as the cancer grows. These include: persistent back pain, blood in the urine, painful or frequent urination, fatigue unexplained weight loss. These symptoms are associated with malignant cancer of the ureter and other health conditions. 

View Report @ http://www.transparencymarketresearch.com/urothelial-carcinoma-treatment-market.html

The treatment of Urothelial carcinoma involves surgery, chemotherapy and radiotherapy. The tests to diagnose Urothelial carcinoma includes Urine tests, Ureteroscopy, Intravenous pyelogram (IVP), Retrograde pyelography, CT scan, MRI scan and Chest X-ray. While the treatment with surgery include open surgery, laparoscopic surgery and percutaneous endoscopic surgery. Chemotherapy treatment usually involves the treatment with a combination of drugs. The combinations includes: gemcitabine and cisplatin, gemcitabine and carboplatin as well as methotrexate, vinblastine, doxorubicin and cisplatin. Radiotherapy is not frequently used for transitional cell carcinoma of the kidney or ureter. Patient may have radiotherapy to the area of the ureter or kidney if patients are not fit enough to have an operation or cancer has spread into surrounding tissue.

The Urothelial carcinoma market has been segmented by type of drugs, by end-user and by geography. The type of drugs sub-segmented as targeted and chemotherapy. The drugs like Levatinib, Atezolizumab, Nivelumab, Enzalutamide, Abiraterone acetate, Cabazitaxel, sipuleucel-T, everolimus, bevacizumab and pazopanib are used in treatment of Urothelial carcinoma. The end-users for the Urothelial carcinoma market include Hospitals, Specialty Clinics, Cancer Research Institutes and Ambulatory Surgical Centers.

Belgium holds the top rank in incidences of bladder cancer, which is followed by Lebanon and Malta. Bladder cancer cases occur in more developed countries, notably around 59%. The regions like Northern America and Europe having highest incidence of bladder cancer; and Asia, Latin America and the Caribbean having the lowest incidence. Transitional cell cancer develops in the part of the kidney called the renal pelvis. Transitional cell cancers are rare and only about 7 out of 100 kidney cancers (7%) diagnosed in the UK. The most common type of kidney cancer is renal cell cancer. Transitional cell cancer of the ureter is even more infrequent than transitional cell cancer of the kidney. TCC of the kidney is 4 times more common than cancer of the ureter. The most common type of bladder cancer is transitional cell cancers of the bladder. According to the estimation of American Cancer Society for bladder cancer, in 2016 there would be about 76,960 new cases of bladder cancer, and about 16,390 deaths from bladder cancer alone in the United States. In recent years the rates of cancer deaths and new bladder cancers have been dropping slightly in women. Incidence rates have been decreasing and death rates have been stable in men. About 5% of all newly diagnosed cancers in the US are Bladder cancers. It is the fourth most frequent cancer in men, but it is not common in women.

Get accurate market forecast and analysis on the Urothelial Carcinoma Treatment Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14060

The major players operating in Urothelial carcinoma market include Genentech, GlaxoSmithKline, Genentech, Novartis, Dendreon, Sanofi Aventis, Bristol-Myers Squibb and Eisai are among other significant players worldwide.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape. 

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urothelial Carcinoma Treatment Market : Evolving Market Trends & Dynamics 2024 here

News-ID: 630485 • Views: 375

More Releases from Transparency Market Research

Hydrogen Peroxide Market to Register a Healthy CAGR of 5.8% for the Forecast Per …
Hydrogen Peroxide Market: Introduction Transparency Market Research delivers key insights on the global hydrogen peroxide market. In terms of revenue, the global hydrogen peroxide market is estimated to expand at a CAGR of 5.8% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecast in its report on the global hydrogen peroxide market. Read report Overview: https://www.transparencymarketresearch.com/hydrogen-peroxide-market.html The global hydrogen peroxide market is broadly affected by several factors
Polyethylene Wax Market to Register a Healthy CAGR of 5.1% for the Forecast Peri …
Polyethylene Wax Market: Introduction Transparency Market Research delivers key insights on the global polyethylene wax market. In terms of revenue, the global polyethylene wax market is estimated to expand at a CAGR of 5.1% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the global polyethylene wax market. Read report Overview: https://www.transparencymarketresearch.com/polyethylene-wax-market.html The global polyethylene wax market is broadly affected by several
Specialty Yeast Market Worldwide With Impressive Sales Trends By 2027
Global Specialty Yeast Market: Overview The demand within the global specialty yeast market is rising on account of advancements in the domain of food processing. Several types of snacks and sauces can be manufactured with the help of specialty yeast, and this is a key consideration from the perspective of market growth. The food and beverages industry is characterised by a robust supply chain, and hence, quick acquisition of specialty foods
IV Bottles Market Applications and Regional Insights during the Forecasted Perio …
According to Transparency Market Research's latest report on the global IV bottles market for the forecast period of 2021-2031, the market is projected to be driven by continuous research & development activities in the pharmaceutical packaging, which are leading to developments in the IV bottles in terms of improving barrier properties, and growing demand for recyclable and sustainable packaging for the product The global IV bottles market is expected to expand

All 5 Releases